Adipose-derived stromal/stem cells (ASCs) are multipotent in nature that can be differentiated into various cells lineages such as adipogenic, osteogenic, and chondrogenic. The commitment of a cell to differentiate into a particular lineage is regulated by the interplay between various intracellular pathways and their resultant secretome. Similarly, the interactions of cells with the extracellular matrix (ECM) and the ECM bound growth factors instigate several signal transducing events that ultimately determine ASC differentiation. In this study, RNA-sequencing (RNA-Seq) was performed to identify the transcriptome profile of osteogenic induced ASCs to understand the associated genotype changes. Gene ontology (GO) functional annotations analysis using Database for Annotation Visualization and Integrated Discovery (DAVID) bioinformatics resources on the differentially expressed genes demonstrated the enrichment of pathways mainly associated with ECM organization and angiogenesis. We, therefore, studied the expression of genes coding for matrisome proteins (glycoproteins, collagens, proteoglycans, ECM-affiliated, regulators, and secreted factors) and ECM remodeling enzymes (MMPs, integrins, ADAMTSs) and the expression of angiogenic markers during the osteogenesis of ASCs. The upregulation of several pro-angiogenic ELR+ chemokines and other angiogenic inducers during osteogenesis indicates the potential role of the secretome from differentiating ASCs in the vascular development and its integration with the bone tissue. Furthermore, the increased expression of regulatory genes such as CTNNB1, TGBR2, JUN, FOS, GLI3, and MAPK3 involved in the WNT, TGFβ, JNK, HedgeHog and ERK1/2 pathways suggests the regulation of osteogenesis through interplay between these pathways. The RNA-Seq data was also validated by performing QPCR on selected up-and down-regulated genes (COL10A1, COL11A1, FBLN, FERMT1, FN1, FOXF1, LAMA3, LAMA4, LAMB1, IGF1, WNT10B, MMP1, MMP3, MMP16, ADAMTS6, and ADAMTS14).
Osteogenic differentiation. ASCs at P2 from 3 different donors were counted and pooled together with equal numbers and plated in 12 well plates at a density of 1 × 10 4 cells/cm 2 and cultured to at least 90% confluence. Osteogenic differentiation was carried out using stromal media supplemented with 10 mM β-glycerophosphate, 50 µg/ml L-Ascorbic acid 2-phosphate sesquimagnesium salt hydrate, and 10 nM dexamethasone for 21 days by replacing media every 3 days 21, 23 . To stain the deposited calcium in extracellular matrix the cells were fixed in 70% ice cold ethanol and stained with 2% alizarin red solution (pH adjusted to 4.1-4.3).
RNA isolation, Reverse transcription, and QPCR. RNA was isolated using the Purelink RNA kit (Life Technologies) according to manufacturer's instructions. The quality and quantity of isolated RNA was measured using nanodrop spectrophotometer. The first strand cDNA synthesis was done by using high capacity cDNA synthesis kit (Applied Biosciences). For quantitative real time PCR sybr green (Applied Biosystems) kit was used as per manufacturer's instructions on abi QPCR machine. Following the QPCR the relative fold change in expression was calculated 2 −(Δ ΔCt) method with GAPDH as internal reference control 24 . All the primer sequences are presented in Supplemental Table S1 .
cDNA Library preparation for RNA-sequencing. SMART-Seq v4 Ultra Low Input RNA Kit for Sequencing (Clontech, Cat. No. 634888) was used to perform cDNA synthesis using template switching technology. Prior to generating the final library for Ion Torrent sequencing, 2.5 µg of cDNA was simultaneously digested with AfaI restriction endonuclease to remove SMART adapters and enzymatically sheared using reagents from the Ion Xpress Plus Fragment Library Preparation Kit (Life Technologies, Cat. No. 4471269). Templates for RNASeq were prepared with the Ion PI ™ Hi-Q OT2 200 template Kit (Life Technologies, Cat. No. A26434) using the Ion OneTouch ™ 2 System for Ion Proton ™ System semiconductor sequencing. These templates were sequenced using the Ion PI ™ Hi-Q Sequencing 200 Kit (Life Technologies, Cat. No. A26433) and Ion PI ™ Chip v3, on the Ion Proton Sequencer. Preliminary analysis of the ensuing sequencing data pertaining to quality of the run, read lengths and coverage were performed using the torrent suite software.
Differential gene expression analysis on RNA-Seq data. The data obtained in FASTQ file format from RNA-sequencing was aligned to ensemble hg38 human genome using the STAR program. RSEM was used to determine the differential expression between undifferentiated and osteogenic differentiated ASCs. The differentiation fold change between undifferentiated and differentiated ASCs was calculated by dividing the number of counts of differentiated sample over number of counts of undifferentiated sample. The genes with the fold change (FC) above 1.5 were considered as upregulated whereas the genes with the fold change (FC) below 0.66 were treated as downregulated and are chosen for further analysis.
Results
To assess the overall gene changes following osteogenic differentiation, three pooled donor ASCs were induced with osteogenic differentiation media for 21 days and next generation RNA sequencing was performed as described in the methods. Confirmation of osteogenic induction was observed through alizarin red stain and is shown in Sup Fig. S1 . Briefly, positive staining was observed in osteogenic medium treated ASCs indicating osteogenic differentiation (Sup Fig. S1 ). After the alignment of RNA-Seq data to the human genome hg38, the expression of pro-osteogenic genes was evaluated to confirm osteognic differentiation (Sup Table S2 ). Most notable osteogenic genes that shown increased expression were BGLAP (Osteocalcin), COL10A1, alkaline phosphatase (ALPL), and BMP4. Visualization and confirmation of enhanced gene expression between control and osteo-induced ASCS were also evaluated through the Integrative Genome Viewer (IGV) 26 . Representative images for individual osteogenic genes are shown in (Sup Fig. S2 ).
Gene ontology functional analysis. To better understand the overall changes induced in ASCs following osteogenic differentiation, total gene changes were evaluated through non-biased means. Amongst all the gene changes, there are ninety three genes above 25 FC, two hundred and sixteen genes between 24.99-10 FC, five hundred and twenty eight genes between 9.99-5 FC, one thousand six hundred and four genes between 4.99-2.5 FC, and three thousand seventy three genes between 2.49-1.5 FC, and for the downregulated, there are one thousand four hundred and twenty two between 0.66-0.4 FC, seven hundred and three between 0.39-0.2 FC, two hundred and sixty six between 0.19-0.1 FC, and one hundred and seventy one below 0.09 FC ( Fig. 1 ). Each cohort group mentioned above was separately subjected to functional annotation analysis using DAVID Bioinformatics Resources 25, 27 to find significantly enriched genes and associated pathways. The non-biased pathway analysis of upregulated gene groups revealed that there was a heavy association with pathways modulating extracellular matrix organization, angiogenesis, cell adhesion regulation of ERK1 and ERK2 cascade, MAPK cascade and regulation of endothelial cell proliferation ( Fig. 2a-d ). While the gene ontology analysis of downregulated genes below also suggested the enrichment of extracellular matrix organization and disassembly, angiogenesis, collagen catabolic process, MAPK cascade, ERK1 and ERK2 cascade, and calcium dependent cell-cell adhesion ( Fig. 3a-d ).
Matrisome gene expression.
The matrisome is defined as the set of all the proteins that comprise in the ECM; they are sub classified into glycoproteins, collagens, proteoglycans, ECM-affiliated, ECM-regulators, and secreted factors 7, 28 . The list of genes encoding matrisome proteins was obtained from matrisome database (http:// matrisomeproject.mit.edu/other-resources/human-matrisome/). We found that 35% of glycoproteins, 22% of collagens and proteoglycans, 41% of ECM-affiliated, 29% of regulators, and 50% of secreted factors were upregulated www.nature.com/scientificreports www.nature.com/scientificreports/ Osteogenic and Angiogenic genes expression. The expression of the osteogenic and angiogenic genes are represented in the heatmaps (Fig. 7a,b ) and in the Sup Tables (S2, S13). It was found that several osteogenic genes such as COL10A1, NOG, BGLAP, ALPL and angiogenic genes such as LEP, ANGPT1, HGF, and several CXC cytokines are upregulated during the osteogenesis of ASCs.
Expression of regulatory genes in WNT, TGF-β, JNK, HedgeHog and ERK1/2 pathways. The expression of major regulatory genes involved in the WNT, TGF-β, JNK, HedgeHog and ERK1/2 pathways are shown in the Fig. 8 and Table 1 . Major regulatory genes of these pathways such as CTNNB1, TGBR2, JUN, FOS, GLI3, and MAPK3 are upregulated indicating the regulation of osteogenesis through interplay between these pathways ( Fig. 8 and Table 1 ).
RNA-Seq validation of differentially expressed genes.
To confirm the RNA-Seq data we have selected the following 16 upregulated genes (LAMA4, FN1, LAMA3, COL10A1, COL11A1, IGF1, FOXF1, FBLN1, WNT10B, and LAMB1) and 5 downregulated genes (MMP1, MMP3, MMP16, ADAMTS6, and ADAMTS14) that are known to have prominent role in the extracellular matrix organization, and cell adhesion pathways. Expression was measured by QPCR and normalized to GAPDH. QPCR evaluation indicates the expression changes of LAMA4, IGF1, FBLN1, LAMB1, FN1, COL11A1, MMP1, MMP3, MMP16 and ADAMTS6 were found to be correlated with the expression changes of these genes revealed by RNA-Seq ( Fig. 9 and Table 2 ). Note that ADAMTS14 was shown to be neither downregulated nor upregulated in the QPCR data. Similar observations can be made for COL10A1, FOXF1, LAMA3 and WNT10B where the QPCR data is not in conformity with the RNA-Seq data. The upregulation of pro-angiogenic cytokines (ANGPT1, HGF and CXC) as well as the ELR+ chemokines (CXCL1, CXCL5, CXCL6, and CXCL8) was also evaluated by QPCR ( Fig. 10 ). The data suggested an increased expression for these cyto-and chemo-kines with the exception of CCL2 gene during osteogenesis of ASCs ( Fig. 10 ). www.nature.com/scientificreports www.nature.com/scientificreports/
Discussion
The role of ECM was once presumed mainly to be static and limited to providing structural support as a matrix. Recent studies have shown the regulatory role of ECM 31, 32 and secretome in the differentiation process 33 . Thus, the development of bone and vasculature and their integration with each other requires robust cell to cell communication between osteoblasts through ECM and secretome. The comprehensive transcriptomic characterization of ECM from ASCs, BMSCs and other MSCs has been reported in literature 34 . However, to our knowledge this is the first study to characterize and correlate the ECM transcriptome and the secretome of ASCs undergoing osteogenesis. GO analysis in biological process category revealed the enrichment of ECM and angiogenesis pathways with both upregulated and downregulated genes in every FC cohort group except 2.49-1.5 FC (Figs 2, 3 ). This output from GO analysis suggests that the potential regulatory role of ECM synthesis and secretome linked to osteogenic differentiation in ASCs. Therefore, we focused on the expression of the ECM genes which make the core matrisome proteins (collagens, glycoproteins and proteoglycans), matrisome associated proteins (ECM-affiliated proteins, ECM-regulators, and secreted factors), ECM remodeling enzymes and secretomic genes. The expression levels of all these matrisome encoding genes under each sub-class in the ASCs undergoing osteogenesis was evaluated (Figs 4-6, Sup Tables S3-S8 , S9-S12).
Collagens are the important components of ECM and also play a crucial role in osteogenesis. Among the upregulated collagens, the expression of COL10A1, COL4A4, COL4A5, COL4A6, COL12A1 and COL24A1 was found to be increased ( Fig. 5 and Sup Table S4 ). COL12A1 and COL24A1 are previously reported to have a role in the regulation of osteogenesis. For example, COL12A1 is crucial for the terminal osteogenic differentiation and also helps in cell-cell communications by regulating gap junction protein, GJA1 35 . It was found the null mice www.nature.com/scientificreports www.nature.com/scientificreports/ with COL12A1 deletion showed altered bone development with reduced bone mass 35 . COL24A1 overexpression enhances osteogenesis while silencing COL24A1 reduces osteogenic potential. COL24A1 interacts with the integrin β3 chain to activate TGF-β/SMADS signaling pathway and thus regulates osteogenesis 36 . COL10A1 is a key marker in the chondrogenesis as its induction will lead to the chondrogenic differentiation in MSCs 37, 38 .
Glycoproteins play important roles in the ECM assembly, cell signaling and binding to growth factors 8 . Laminins and fibulins are well known categories of glycoproteins. Laminins are the heterotrimeric glycoproteins, with 3 different chains α, β, and γ, that are found primarily in the basement membrane and mediate cell adhesion, proliferation, migration, differentiation and angiogenesis 39 . In laminins, we have the upregulation of LAMA1, LAMA2, LAMA3, and LAMA4 ( Fig. 5 , Sup Table S3 ). The pro-angiogenic properties of Laminin alfa 1(LAMA1) chain have been well documented. The peptide with amino acid sequence SIKVAV derived from LAMA 1 when injected into nude mice along with melanoma cells promoted tumor growth by enhancing the angiogenesis of the tumor 40 . Similarly, A13 and AG73 peptides from LAMA1 were found to be robust angiogenic inducers 41, 42 . Furthermore, C57BL/6J mice with a missense mutation in the LAMA1 gene develops abnormal retinal vasculature leading to impaired inner limiting membrane formation 43 . On the other hand, transfecting LAMA1 chain in HT29 colonic cancer cells increased angiogenesis by recruiting fibroblasts that led to the significant growth in tumor 28 .
LAMA4 subunit expression restricted to certain tissues and is mainly found in vascular endothelial basement membranes of brain, muscle, and bone marrow. Antibodies against the G1/G2 domain of LAMA4 subunit impede the branching morphogenesis of microvascular endothelial cells 44 . LAMA4 deficient mice develops impaired microvessel organization with poor structural integrity leading to hemorrhage in subcutaneous tissues 45 . More importantly, the G domain of LAMA4 chain has shown to exhibit high affinity to bind to integrins, www.nature.com/scientificreports www.nature.com/scientificreports/ α3β1 and αVβ3, on endothelial cells which ultimately leads to angiogenesis 46 . LAMA2 is majorly found in the basement membrane surrounding skeletal muscle and mutation in this gene can cause poor muscle development leading to muscular dystrophy 47 . Laminin 332, similar to other laminins is found in basement membranes, aids in cell migration and invasion. The interactions between LAMA3 subunit of laminin 332 with α6β4 integrin and syndecan 1 leads to the activation of protein kinase C (PKC) pathway which causes tumor cell migration and invasion 48 .
The two fibulins, FBLN1 and FBLN5, are found to be upregulated during osteogenesis (Fig. 5 , Sup Table S3 ). FBLN1 enhances the osteogenesis (both endochondral and intramembranous) by positively regulating of BMP2 and Osterix 49 . Lack of FBLN1 expression in the perinatal mice resulted in the improper skull development and premature death 50 . In FBLN5 deficient mice pre-maxillary bone defects are observed and FBLN5 is crucial for the MSCs proliferation within the facial suture 51 . Other notable glycoproteins upregulated that are known to regulate osteogenesis and angiogenesis are Fibronectin FN1, BMPER, VWF, THBS1, FRAS1, and NID1 ( Fig. 5 , Sup Table S3 ).
Proteoglycans are mainly found in the ECM of connective tissues and facilitate hydrodynamic swelling of the tissue to sustain the external compressional forces 52 . HAPLN1 and Osteoglycin (OGN) are two proteoglycans that are increased in expression due to osteogenic induction in ASCs (Fig. 5 , Sup Table S5 ). In MC3T3-E1 cells, overexpression of OGN reduced the expression of RUNX2 and Osterix while significantly upregulated ALPL, type I collagen (Col1), and osteocalcin (OCN), β-catenin and calcium mineralization 53 .
The ECM remodeling enzymes (MMPs and ADAMTSs) are known to degrade ECM as a part of ECM repair and remodel process. The MMPs 2, 5, 28 and the ADAMTSs 18, 15, 8, 13 are overexpressed in the ASCs undergoing osteogenesis (Fig. 6 , Tables S9 and S10). MMP2 is known to play key role in the wound healing process by degrading type IV collagen 54 and is also found to be significantly expressed by osteoarthritic cartilage 55 . MMP28 is also known to be involved in wound healing and repair process in the injured keratinocytes and testis 56 . ADAMTS18 is a bone mass candidate gene where the loss of expression is directly correlated to skeletal fractures 57 . ADAMTS8 and ADAMTs15 are shown to be the clinical markers of breast cancers 58 whereas ADAMTS13 is known to regulate blood clotting through mediating the von Willebrand factor (VWF) 59 .
The overall fate of angiogenesis is dependent on the balance between angiogenic and angiostatic factors. CXC chemokines contain two conserved cysteine (C) residues towards the amino terminus and are separated by any other amino acid represented as X. The CXC chemokines with amino acids, glutamic acid-leucine-arginine (termed as ELR motif) towards the amino terminal side of the first cysteine residue are ELR positive CXC chemokine which are regarded as proangiogenic while the CXC chemokines without ELR motif are angiostatic 60, 61 . Examples of ELR+ CXC chemokines are CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8. We found increased expression of ELR+ chemokines especially CXCL1, CXCL5, CXCL6 and CXCL8 during osteogenesis ( Fig. 7b and Sup Table S13 ). It was demonstrated that CXCL1 secreted by human endothelial cells increases rate of angiogenesis by autocrine response and effects surrounding epithelial cells by paracrine www.nature.com/scientificreports www.nature.com/scientificreports/ signaling while blocking CXCL1 resulted in decreased ability to induce angiogenesis 62 . Furthermore, CXCL1 results in the expression of EGF, another angiogenic inducer, through ERK1/2 pathways mediation 62 . Consistent with this, we found the upregulation ERK1/2 pathways indicating CXCL1 mediated autocrine signaling in osteogenic induced ASCs (Fig. 2b,d) . CXCL8 is another angiogenic chemokine whose expression was found to be increased in osteogenesis. Similar to CXCL1, CXCL8's expression correlates to the angiogenic development in human pancreatic, ovarian and non-small lung cancer (NSLC) 63 . CXCL5, along with CXCL8, also plays a crucial role in mediating angiogenesis in NSLC whose expression levels correlates with angiogenic potential 64 . In MSCs, overexpression of CXCL6 enhances the upregulation of pro-angiogenic genes such as VEGF-A, IGF-1, HGF and CXCL8 65 . The secretome from cardiac progenitor cells containing CXCL6, CXCL1, and CXCL8 promoted angiogenic activity of HUVEC cells 66 . QPCR studies performed to confirm the upregulation of ELR+ chemokines (CXCL1, CXCL5, CXCL6, and CXCL8) and other pro-angiogenic cytokines (ANGPT1, HGF, and CCL2) suggested the increased expression of these genes ( Fig. 10 and Table 2 ). Contrary to the upregulation of CCL2 gene as indicated by RNA-Seq, we found the downregulation of CCL2 by QPCR while all other pro-angiogenic genes Figure 10 . Expression of pro-angiogenic cytokines during osteogenesis. The upregulation of pro-angiogenic cytokines determined using RNA-Seq is also observed by QPCR with the exception of CCL2 gene. www.nature.com/scientificreports www.nature.com/scientificreports/ studied by QPCR showed increased expression as indicated by RNA-Seq ( Fig. 10 and Table 2 ). The upregulation of these ELR+ chemokines during osteogenesis suggests the possible paracrine effect to induce angiogenesis of the endothelial progenitor cells in vicinity.
RNA-Seq QPCR
The expression of major regulators of WNT signaling pathway, TGF-β signaling, HedgeHog, and ERK pathways are shown (Fig. 8 ). WNT signaling has been shown to upregulate osteogenesis through both β-catenin dependent and β-catenin independent pathways [67] [68] [69] . The binding of WNT ligands to the frizzled receptors (Frz) facilitates a complex formation that involves a transmembrane receptor low-density lipoprotein receptor-related protein 5 (LRP5) with a disheveled proteins (DVL1, DVL2) 70 . The disheveled proteins inhibit the complex (Axin, GSK3β, APC) that degrades β-catenin (CTBBN1) which eventually translocates to the nucleus, hetero-dimerizes www.nature.com/scientificreports www.nature.com/scientificreports/ with lymphoid enhancer-binding factor/T cell factor (LEF/TCF) and regulates transcriptional process. The expression of CTBBN1, LRP5, LEF1, and DVL2 are found to be increased during osteogenesis of ASCs indicating that the β-catenin dependent canonical WNT signaling pathway is likely regulating osteogenesis ( Fig. 8 , Table 1 ). TGF-β signaling is also in regulating osteogenesis through TGF-β receptors and SMADs 3 . The binding of ligands to TGF-β receptors (TGFBR1 and TGFBR2) elicits the SMAD proteins especially SMAD2, SMAD3, and SMAD4 to form a complex that translocates to nucleus to regulate gene activity whereas SMAD7 disintegrates the SMAD2/3 and SMAD4 complex preventing it from entering the nucleus 3 . The expression of TGFBR2 is increased and SMAD7 (inhibitor of SMAD2/3 and SMAD4 complex) expression decreased while the expression of SMAD2/3 and SMAD4 remained unchanged in our data suggesting the possibility of TGF-β regulation of osteogenesis in ASCs (Fig. 8 , Table 1 ). HedgeHog pathway is also known to influence osteogenic pathway through the transcription factor Gli3 67 . The expression of Gli3 was found to be upregulated suggesting the likelihood of hedgehog pathway's involvement (Fig. 8 , Table 1 ).
The AP-1 complex proteins mainly c-JUN (JUN) and c-FOS and the MAPK10 (JNK3 enzyme) are found to be upregulated during osteogenesis indicating that JNK pathway is also involved in osteogenic regulation. The expression of MAPK3, a major enzyme of ERK1/2 pathway, was found to be increased suggesting that ERK1/2 pathway involvement in osteogenesis ( Fig. 8 , Table 1 ). The upregulation of both MAPK signaling pathways (JNK and www.nature.com/scientificreports www.nature.com/scientificreports/ ERK1/2) was also indicated by GO functional analysis ( Fig. 2b-d ) as these two pathways were significantly enriched. The enrichment MAPK signaling pathways and AP1 transcription factor (JUN) has also been demonstrated in a recent study by Martin et al., where ASCs were treated with serum from heterotopic ossification patients in a ectopic bone formation model 71 . Overall, this data suggests that the interplay and crosstalk between WNT, TGF-β, JNK, HedgeHog and ERK1/2 pathways regulates osteogenesis in ASCs through the ECM and pro-angiogenic secretome release that could function as paracrine signaling facilitating the vascularization of bone tissue.
Comparative analysis between ASCs and BMSCs secretome during osteogenesis. The secretome
of BMSCs undergoing osteogenesis was analyzed by Kim et al. 72 using LC-MS/MS technique. Kim et al., identified 315 secretome proteins out of which 177 were upregulated during osteogenesis of BMSCs (Fig. 11a ). We have examined the genes coding for those 315 proteins identified by Kim et al. 72 in our ASC data. In the ASCs, during the osteogenic differentiation, 67 secretome genes were found to be upregulated of which 46 of them were found to be in common between ASCs and BMSCs (Fig. 11a,c and Table 3 ). There are 21 genes (the difference between 67 and 46) which are upregulated exclusively in ASCs ( Fig. 11d and Table 4 ). Gene ontology (GO) analysis performed on each of these categories suggest the enriched pathways as cell-cell adhesion, collagen catabolic process, endothelial cell migration, and ECM regulation with all the upregulated ASC secretome genes (Fig. 11b ). While the GO analysis with the genes exclusively expressed in ASCs revealed the enrichment of insulin-like growth factor (IGF) receptor signaling pathway, ECM regulation, response to hypoxia, collagen catabolic process, cell adhesion pathways (Sup Fig. S3 ). Although up-and down-regulated pathways/proteins/genes during BMSCs osteogenesis are reported in the literature 33, 67, 70, 72 , the raw RNA-Seq data that will be enable us to perform a comparative analysis isn't easily accessible. Further studies are clearly required to better our understanding of the differences and the commonalities in the differentiation pathways of BMSCs and ASCs.
Conclusion
In this study, we used RNA-Seq to determine the differential gene expression between undifferentiated ASCs and ASCs induced into osteogenesis on day 21. The differentially expressed genes were subjected to gene ontology functional analysis that revealed the enrichment of ECM and angiogenesis along with ERK1/2 and JNK pathways. The expression of matrisome genes (glycoproteins, collagens, and proteoglycans) and the expression of ECM remodeling enzymes (MMPs and ADAMTSs) and integrins with respect to osteogenesis in ASCs has been elucidated. The change in the expression patterns of pro-angiogenic genes between differentiated and undifferentiated ASCs into osteogenic lineage was evaluated and it indicates the secretion of several pro-angiogenic ELR+ chemokines and other angiogenic inducers suggesting the possible regulatory role of differentiating ASCs in the development of vasculature to accomplish functional bone formation. The depicted results suggest that the ECM and angiogenic gene expression varies with the induction of osteogenesis in ASCs. The expression of regulatory genes such as CTNNB1, TGBR2, JUN, FOS, GLI3, and MAPK3 involved in the WNT, TGF-β, JNK, HedgeHog and ERK1/2 pathways are found to be upregulated suggesting the regulation of osteogenesis through interplay between these pathways. Further validation of RNA-Seq data was performed by QPCR. 
